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Although aberrations in adhesion molecule expression
by lymphoma cells have been reported, the functional
consequences of these changes are unclear. Herein, we
report a patient with SeÂzary syndrome whose malig-
nant peripheral blood T cells were TCRVb17+.
Malignant T cell adhesion molecule abnormalities
included an 80% downregulation of LFA-1 compared
with normal controls and no detectable expression of
a4 integrin. Under shear stress conditions, malignant
T cells failed to arrest on recombinant ICAM-1 in the
presence of chemokines and displayed an 80%
decrease in the ability to arrest on TNF-a activated
dermal microvascular endothelial cells compared with
normal CD4+ memory T cells. Cutaneous lympho-
cyte-associated antigen expression was detected in
~25% of malignant T cells in the peripheral blood, but
was substantially less than this in TCRVb17+ T cells in
the dermis. By contrast, > 95% of malignant T cells in
peripheral blood expressed L-selectin (CD62L), and
L-selectin ligand was detected in dermal blood vessels
at affected skin sites. Compared with normal CD4+,
malignant T cells attached and rolled 6-fold more
ef®ciently on L-selectin ligand (p < 0.0001). Thus,
despite aberrant expression of LFA-1 and functional
defects in the ability to arrest on activated endothelial
cells, malignant T cells in this patient entered skin and
produced signi®cant clinical disease. We propose a
mechanism by which the upregulated expression of
L-selectin and L-selectin ligands may partially
compensate for altered LFA-1 function. Key words:
adhesion molecules/integrin/L-selectin/lymphoma. J Invest
Dermatol 116:466±470, 2001
C
utaneous T cell lymphomas (CTCL) comprise a
group of rare non-Hodgkin's lymphomas in which
(usually) CD4+CD45RO+ memory T cells (mTC)
traf®c to skin and produce cutaneous disease. SeÂzary
Syndrome (SS) is the leukemic form of CTCL, and
patients classically present with erythroderma, lymphadenopathy,
and variable degrees of T cell epidermotropism. By de®nition,
malignant clonal T cells comprise more than 5% of the total white
blood cell count in the peripheral blood in SS (reviewed in Kim
and Hoppe, 1999).
The mechanisms by which malignant T cells home speci®cally to
skin are thought to be related in part to the speci®c expression of
cell surface receptors. Under in¯ammatory conditions, dermal
microvascular endothelial cells upregulate E-selectin that then
interacts with its ligand (the cutaneous lymphocyte-associated
antigen (CLA; Picker et al, 1990)) on T cells to initiate rolling.
CLA+ T cells correlate with extent of disease in SS and decline with
clinical remission (Heald et al, 1993). Several lines of experiment
data suggest that L-selectin/CD62L and its ligand(s) (termed
peripheral node addressin [PNAd]) may also play a role in the
migration of T cells to cutaneous sites (see Discussion). Lastly,
LFA-1 (CD11a/CD18) integrin expression by T cells (Shiohara
et al, 1989) and ICAM-1 expression by keratinocytes (Nickoloff
et al, 1989) have been proposed to play a role in the
epidermotropism of malignant T cells. Of note, the expression of
LFA-1 and/or CD18 integrins has been reported to be markedly
diminished in 44% of non-Hodgkin's lymphomas (Medeiros et al,
1989), which may play a role in evading immune surveillance
(Clayberger et al, 1987).
Herein, we report a SS patient with malignant T cells in both
skin and peripheral blood. Adhesion molecule expression by the
malignant T cells was downregulated in the case of CD11a, CD18,
and a4 integrins and upregulated in the case of L-selectin. Utilizing
a parallel plate ¯ow chamber, we noted striking functional
consequences under physiologic ¯ow conditions. We propose that
the upregulated expression of L-selectin on CTCL cells may
explain the paradoxical migration of malignant T cells to skin
despite the dramatic adhesion defects we observed in vitro.
MATERIALS AND METHODS
Description of case The patient is a 78-y-old Caucasian female with a
6-y history of CTCL. Prior therapies included multiple topical and systemic
chemotherapies, which were either ineffective or caused excessive toxicity.
Her skin showed large patches of erythroderma and elevated plaques with
overlying scale affecting > 50% of her body surface. A skin biopsy showed a
dense dermal in®ltrate consisting of large T cells with cerebriform nuclei.
Minimal epidermotropism and spongiosis were present in the epidermis.
An 18-¯uorodeoxyglucose Positron Emission Tomography scan showed
uptake in the axillary and inguinal nodes but no uptake in the skin. A
lymph node (LN) biopsy from 1994 was positive for malignant T cell
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involvement. A complete blood count showed an elevated white count of
14.8 3 103 per mm3 consisting of 36% neutrophils, 2% lymphocytes, and
57% small-medium sized cells with high nuclear content and SeÂzary cell
morphology. Flow cytometric analysis showed that her T cells were > 93%
CD45RO+, CD4+, and CD7+. Patient-derived tissue and blood were
collected with consent per protocol (00-C-0068) while she had been off
systemic therapy for at least 2 mo. The patient subsequently underwent
experimental therapy at NIH with clearing of many skin lesions and
decreases in her SeÂzary cell count and was unavailable for further
experiments.
Reagents FITC-anti-human TCRVb-speci®c monoclonal antibodies
(MoAb) and anti-CD29 (mIgG1) were purchased from Endogen (Boston,
MA). Anti-human CD45RO (UCHL1, mIgG2a), CD45RA (HI100,
mIgG2b), anti-PNAd/L-selectin ligands (MECA-79, rat IgM), anti-CLA
(HECA452, rat IgM), PE-anti-CD49d (9F10, mIgG1), FITC-anti-CD11a
(HI10a, mIgG1), FITC-anti-CD18 (6.7, mIgG1), and unlabeled and
CyChrome-antihuman CD62L (Dreg56, mIgG1) were purchased from
BD-Pharmingen (San Diego, CA). E-selectin/human Ig chimera (Erbe
et al, 1992) and puri®ed GlyCAM-1 were gifts of S.D. Rosen (UCSF,
San Francisco, CA). A nonfunction blocking anti-human ICAM-1
MoAb (P79) and soluble human ICAM-1 (sICAM-1) were gifts of
T.K. Kishimoto (Boehringer-Ingelheim Pharmaceuticals, Ridge®eld,
CT). Recombinant chemokines were purchased from Peprotech (Rocky
Hill, NJ).
Two-color confocal microscopy Punch biopsies of skin (4 mm) were
obtained from the patient and frozen in OCT (Sakura Finetek, Torrance,
CA). Acetone-®xed sections (6 mm) were blocked with phosphate-buffered
saline (PBS)/2% fetal calf serum prior to staining with unlabeled antibodies
(i.e., anti-CLA or anti-PNAd) at 5 mg per ml for 30 min at room
temperature. After washing, a biotinylated mouse anti-rat IgM secondary
MoAb followed by Cy3-strepavidin (Caltag, San Bruno, CA) along with
FITC-labeled Vb speci®c MoAb (1:100 dilution) was added to the
sections. Fluorescence was visualized with a Nikon PCM200 confocal
microscopy.
Flow cytometry Fresh peripheral blood was centrifuged over
Histopaque 1007 (Sigma, St. Louis, MO), and the mononuclear fraction
was cultured overnight in complete RPMI 1640 medium including 10%
fetal calf serum, and antibiotics/antifungal agents (cRPMI). CD4+
CD45RO+ mTC (> 95% pure) were isolated by negative depletion with
CD19, CD14, and CD8-conjugated Dynal beads (Dynal, Lake Success,
NY) followed by further depletion with anti-human CD45RA/sheep anti-
mouse-conjugated Dynal beads. T cells were stained with the indicated
antibodies and washed in PBS before resuspension in PBS/0.1% bovine
serum albumin (BSA) for ¯ow cytometric analysis. All ¯ow cytometric data
were con®rmed by a second experiment at a later time using another
normal volunteer as a control.
In vitro ¯ow adhesion assay Human mTC populations were isolated as
described above. Where indicated, mTC were treated with pertussis toxin
(PTX, 100 ng per ml, Sigma, St. Louis, MO) for 1.5±2 h at 37°C. mTC
were allowed to equilibrate at 37°C for 30 min before the ¯ow assay and
then suspended in a 12 ml syringe, which was ®xed to a precision syringe
pump (Harvard Apparatus, Holliston, MA).
For ¯ow assays using recombinant proteins, E-selectin/human Ig,
chemokines, and soluble ICAM-1 were applied to 35 mm nontreated
plastic culture dishes as described (Fitzhugh et al, 2000). To test rolling of T
cells on L-selectin ligand, af®nity-puri®ed murine GlyCAM-1 (Singer
and Rosen, 1996) (a soluble L-selectin ligand secreted into serum by
LN high endothelial cells) was used to coat plastic plates at ~1 mg per ml
in tris-buffered saline pH 9.0 overnight at 4°C. No chemokines were
added and PBS/0.1% BSA was used to block nonspeci®c binding. A parallel
plate ¯ow chamber apparatus (Glycotech, Rockville, MD) was af®xed to
the tissue culture plate using a rubber gasket and a continuous vacuum. For
T cell attachment experiments using endothelial cells, HDMEC were
grown, stimulated with TNF-a, and used in adherence experiments as
described (Fitzhugh et al, 2000). In all experiments, T cells (5 3 105 cells
per ml in cRPMI) were pumped into the chamber at a shear stress of 1.5
dynes per cm2 at room temperature. After allowing 5 min for interactions to
establish, randomly selected ®elds were videotaped and subjected to digital
video analysis of 10 s segments to quantify numbers of both rolling and
arrested cells during the 10 s time frame. Results are expressed as the mean
ratio of adherent:rolling cells (10 ®elds were analyzed per condition).
Statistical signi®cance (Student's t test) was calculated using Microsoft
Excel.
RESULTS
Expression of adhesion molecules and chemokine
receptors We screened the patient's peripheral blood
lymphocytes for expression of speci®c T cell receptor b chain
variable (Vb) regions using MoAb. Given the large number of
possible variations in the b chain of the TCR, < 8% of lymphocytes
in peripheral blood in normal individuals should express any one
Vb epitope. Due to clonal expansion in SS, however, 59%±87% of
all peripheral blood lymphocytes may express a single Vb epitope
(Heald et al, 1994). Strikingly, > 95% of the patient's peripheral
blood lymphocytes (as de®ned by forward and size scatter
parameters and CD3 expression) displayed the Vb17 epitope
(Fig 1A). Other Vb epitopes tested (Vb 3.1, 5a, 6.7, 8a, 13 (not
Figure 1. Flow cytometric studies of cell surface adhesion mole-
cules on normal and malignant T cells. After isolation of patient and
control CD4+ mTC by differential density separation, lymphocytes were
stained with MoAb for the indicated cell surface markers and analyzed by
¯ow cytometry. (A) Dark region: isotype control MoAb. Solid line: Vb-
speci®c MoAb. (B, C) Dark region: isotype-matched control MoAb. Solid
line: control lymphocytes, speci®c MoAb. Dotted line: patient lympho-
cytes, speci®c MoAb. The percentages of CLA+ cells for patient and
control were 23% and 25%, respectively, in this experiment. More than
ninety-®ve per cent of patient T cells were L-selectin positive. Similar
results were obtained in comparisons with two healthy donors.
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shown), and 12 (Fig 1A)) represented < 5% of the patient's
lymphocytes.
In order to determine whether expression of cell surface
adhesion molecules were altered in this patient, we stained her
lymphocytes with speci®c MoAb and quanti®ed expression by ¯ow
cytometry. CLA was expressed on ~25% of the patient's
lymphocytes (Fig 1B). As nearly all the patient's lymphocytes
expressed Vb17, this also meant that approximately 25% of her
malignant T cells also expressed CLA. In contrast to the partial
expression seen with CLA, L-selectin was expressed by ~95% of her
malignant T cells (Fig 1B). As shown in Fig 1(C), the SeÂzary cells
were de®cient in CD18 and CD11a ± the two integrin chains that
make up LFA-1, an adhesion molecule thought to be critical for T
cell adhesion to endothelial cells (Oppenheimer-Marks et al, 1990).
CD18 and CD11a were reduced by ~80% when compared with
CD4+ mTC from two different control donors. Moreover, the
malignant T cells did not express the a4 integrin chain although b1
integrin was normally expressed on the cell surface (Fig 1C). Thus,
malignant mTC in this patient demonstrated aberrant adhesion
receptor expression, namely upregulation of L-selectin and down-
regulation of LFA-1 and a4 integrins.
Reduction in CD11a/CD18 leads to altered ®rm arrest of T
cells on both recombinant substrates and activated
HDMEC To address whether aberrant LFA-1 expression might
lead to functional defects under physiologic ¯ow conditions, we
isolated patient and control CD4+ mTC for use in parallel plate
¯ow chamber experiments in which the surface was coated with E-
selectin, ICAM-1, and chemokines. In our experience, stromal-
derived factor (SDF)-1 is the most effective chemokine inducer of
arrest for mTC (DF and STH, unpublished data). The patient's
lymphocytes attached and rolled on this surface but, in contrast to
normal CD4+ mTC, failed to ®rmly arrest in the presence of SDF-1
as indicated by an arrest-to-rolling ratio that was far lower that than
observed with a control donor (Fig 2C). We tested the patient's
lymphocytes with two other chemokines, liver and activation-
regulated chemokine (LARC)/MIP-3a, which acts via CCR6, and
thymus and activation-regulated chemokine (TARC), which acts
via CCR4, to determine whether this defect was speci®c for
CXCR4. These two chemokines have been postulated to play a
role in the speci®c homing of mTC to skin (Campbell et al, 1999;
Homey et al 2000). As was the case with SDF-1, TARC (Fig 2A)
and LARC (Fig 2B) were able to induce arrest in the control, but
not patient, lymphocytes. In ®lter-based chemotaxis assays, both
TARC and SDF-1 were able to strongly stimulate chemotaxis of
patient lymphocytes (STH, unpublished data), suggesting that a
generalized defect in the patient's chemokine receptors was not
present.
To determine whether this defect in ®rm arrest could be
observed in a more physiologic system where other adhesion
molecules besides ICAM-1 were available for arrest, we tested the
ability of the patient's lymphocytes to roll and arrest on TNF-a-
activated HDMEC. We had previously shown that in this system
human memory T cell interaction was dependent upon E-selectin,
CLA, and pertussis toxin (Fig 2D) as previously described
(Fitzhugh et al, 2000). The patient's lymphocytes rolled, but
inef®ciently arrested, on activated HDMEC (Fig 2D). Analysis of
the mean ratio of adherent to rolling cells showed that her cells
arrested only 20% as ef®ciently as normal memory CD4+ T cells.
The patient's malignant T cells expressed 2-fold more L-selectin
than L-selectin+CD4+ mTC from normal controls (Fig 1B). To
determine whether the L-selectin expressed by CTCL cells was
functional, these cells were applied under shear stress to plastic
plates coated with an af®nity-puri®ed L-selectin ligand termed
GlyCAM-1, a bona®de rolling substrate for lymphocytes (Dwir
et al, 1998). CTCL cells showed a ~6-fold increase in the number
of cells rolling per ®eld compared with CD4+ mTC at 1.5 dynes
per cm2 (Fig 2E), suggesting that these cells may attach more
ef®ciently to L-selectin ligands than normal CD4+ mTC.
Figure 2. Patient lymphocytes exhibit severe defect in ®rm arrest on
recombinant ICAM-1 and on activated HDMEC but ef®ciently roll
on L-selectin ligand. Patient and control CD4+ mTC were isolated and
used in in vitro parallel plate ¯ow chamber assays as described in Materials
and Methods. (A±C) Normal and CTCL lymphocytes were ¯owed over
recombinant adhesion molecules co-coated with the following chemo-
kines: (A) TARC, (B) LARC/MIP-3a, or (C) SDF-1a. (D) Normal and
CTCL lymphocytes with and without PTX treatment were ¯owed over
TNF-a activated HDMEC. One of two representative experiments for
(A)±(C). A single experiment was performed for (D) because of limited
numbers of patient cells. The Y-axis displays mean adherent to rolling cells
per ®eld 6 SD. (E) GlyCAM-1 was coated onto plastic plates as described
in Materials and Methods. As observed by phase microscopy with a 43
objective, rolling interactions were captured on videotape 5 min after
initiation of ¯ow at 1.5 dynes per cm2 from four different ®elds for at least
15 s each from normal versus patient samples. Software-aided (NIH Image
1.62 with macros provided by K. Tangemann) sequential superposition of
10 frames captured every 0.5 s (see inset in upper left corner for
representative raw analyses of 5 s captures) were used to quantify numbers
of rolling cells during four (5 s each) analysis periods for each group of T
cells. The Y-axis shows mean numbers of rolling cells per video ®eld 6 SD
(n = 4, p < 0.0001).
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L-selectin ligands are expressed by patient's dermal vascular
endothelial cells in lesional skin The speci®c reactivity of the
malignant T cells with anti-Vb17 MoAb provided a tool by which
we could unequivocally identify malignant T cells in the skin.
Using confocal ¯uorescence microscopy, double-staining for the
mTC marker, CD45RO, revealed that nearly all of the Vb17+
malignant T cells were of the memory phenotype (not shown).
While we observed scattered CLA+ cells in the epidermis and in the
papillary and reticular dermis, these CLA+ cells did not generally
correspond with cells that had Vb17 reactivity, suggesting that most
of the malignant T cells were not CLA+ (data not shown). To
determine which adhesion molecules were expressed by vascular
endothelial cells in this patient's skin, we stained sections of skin
with MECA-79 (Michie et al, 1993), which recognizes
carbohydrate-based L-selectin ligands (i.e., PNAd) in both mouse
and man. Indeed, many of the blood vessels in the deep reticular
dermis stained positively for L-selectin ligands (red staining, Fig 3)
and were surrounded by dense collections of Vb17+ malignant T
cells (green cells, Fig 3). Some of these vessels (white box
highlighted in Fig 3) displayed morphology similar to the
L-selectin ligand-rich high endothelial venules (HEV) of
secondary lymphoid organs. Staining with isotype-matched rat
IgM control MoAb was negative. Occasional blood vessels also
stained positively for E-selectin (not shown). Sections were also
stained for L-selectin, but reactivity was not observed (data not
shown).
DISCUSSION
A signi®cant fraction of non-Hodgkin's lymphomas (in particular B
cell lymphomas) express little or no LFA-1, but alterations in the
levels of LFA-1 in SS/CTCL have not been noted in the limited
number (13) of patients studied to date (Medeiros et al, 1989;
Savoia et al, 1992). Thus, we provide the ®rst case of aberrant LFA-
1 expression by malignant T cells in CTCL and demonstrate that
this leads to an adhesion de®ciency in vitro under shear stress
conditions.
How can the apparent defect in T cell adherence to activated
endothelium be reconciled with the large numbers of malignant T
cells in the skin and subsequent clinical severity? Although the rate
of adhesion to activated endothelium was reduced in vitro to ~20%
of normal, even a relatively low ef®ciency of adherence may lead to
clinically meaningful numbers of T cells migrating from the blood
stream into skin given a suf®cient rate of initial interactions with
activated endothelial cells. We have noted two features in this
patient that might increase initial interactions: (1) uniform
expression of L-selectin on malignant T cells, and (2) abundant
expression of L-selectin ligand on dermal endothelial cells.
Compared with CLA expression of only ~25% of the CTCL cells,
uniform expression of L-selectin may theoretically increase initial
rolling interactions with dermal endothelium by up to 4-fold and
yield a higher number of adherent cells than would be found by
E±selectin interactions alone. Indeed, our in vitro ¯ow studies
(Fig 2E) demonstrated a striking 6-fold increase in tethering and
rolling of the CTCL cells versus normal CD4+ mTC on L-selectin
ligand. Just as we had detected MECA-79 reactive vessels in the
skin of this patient, L-selectin ligands have been reported to be
expressed by vascular endothelial cells in chronic in¯ammatory
dermatoses (Mackay et al, 1992; Michie et al, 1993) and in CTCL
(Lechleitner et al, 1999), where it has been proposed to in¯uence
migration of T cells. Therefore, it is possible that malignant T cells
in this case use the L-selectin pathway to increase initial interactions
with PNAd+ vessels in order to increase numbers of T cells that
arrest and extravasate. Additionally, upregulation of L-selectin may
have also contributed to LN involvement in this patient.
Our ability to tag malignant T cells with a speci®c marker
(Vb17) has allowed us to determine that the majority of malignant
T cells in the skin of our patient were not CLA+. If CLA expression
were strictly required for T cell migration into skin, one might
expect that nearly all T cells in skin would be CLA+ as has been
reported in other skin conditions (Borowitz et al, 1993). Thus,
L-selectin/L-selectin ligand interactions may play a major role in
the homing of T cells to skin independent of CLA under certain
conditions. These may include chronic in¯ammatory states since
several experimental models suggest that L-selectin ligands do not
appear (Mackay et al, 1992) or are not critical in the ®rst 3 d of an
immune response (Tang et al, 1997).
We did not observe L-selectin expression by the patient's
malignant T cells in affected skin tissue. This was not completely
surprising in that L-selectin is proteolytically cleaved (shed) from
the surface of leukcocytes (including lymphocytes) during rolling
interactions (Walcheck et al, 1996) and under a variety of activating
conditions (Buhrer et al, 1990; Palecanda et al, 1992).
LFA-1 has been used as a target for the therapy of lymphoma
(Zahalka et al, 1993) and T cell-mediated in¯ammatory skin
diseases such as psoriasis (Gottlieb et al, 2000). Although these
reports are promising, our data suggest that signi®cant clinical
disease can occur even when LFA-1 expression is only 20% of
normal ± a level at which functional impairment in vitro was clearly
demonstrated in this patient. Altered expression of adhesion
receptors may provide malignant T cells with the capability to
migrate to tissue despite impairment of certain key elements of
migration found in normal T cells. The success of future therapies
directed against CD11a/CD18 may also depend upon the degree to
which other integrin-dependent functions such as T cell activation
or cytotoxic function are also inhibited.
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Figure 3. Expression of adhesion markers on CTCL lymphocytes
and vascular endothelial cells in affected skin. Skin from affected areas
was double-stained with MECA-79 (103 objective) followed by a
secondary antibody with Cy3 labeling (red) in conjunction with FITC-
anti-Vb17 (green). For orientation, the large white arrow is adjacent and
orthogonal to the epidermis and points away from the dermis. The bottom
of the shaft of this arrow touches the corni®ed layer of the epidermis. The
small white box highlights an elongated HEV-like dermal vessel that
strongly stains positive for L-selectin ligands and is surrounded by Vb17+ T
cells.
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